MVC's H7N9 Phase I/II clinical trial fulfills the funding requirement of Fast Track Clinical Trial Project and received 14.03 million TWD from Ministry of Economic Affairs.
Medigen Vaccine Biologics Co. received 14.03 million TWD funding from Ministry of Economic Affairs for H7N9 Phase I/II clinical trial
2015/10/16